Pacifica Partners’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $16 | Hold |
8
| – | – | ﹤0.01% | 402 |
|
|
2026
Q2 | $15 | Hold |
8
| – | – | ﹤0.01% | 423 |
|
|
2026
Q1 | $16 | Hold |
8
| – | – | ﹤0.01% | 450 |
|
|
2025
Q4 | $17 | Hold |
8
| – | – | ﹤0.01% | 434 |
|
|
2025
Q3 | $41 | Hold |
8
| – | – | ﹤0.01% | 495 |
|
|
2025
Q2 | $49 | Hold |
8
| – | – | ﹤0.01% | 520 |
|
|
2025
Q1 | $42 | Hold |
8
| – | – | ﹤0.01% | 510 |
|
|
2024
Q4 | $39 | Hold |
8
| – | – | ﹤0.01% | 478 |
|
|
2024
Q3 | $54 | Hold |
8
| – | – | ﹤0.01% | 500 |
|
|
2024
Q2 | $58 | Buy |
+8
| New | +$79 | ﹤0.01% | 528 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$99 | – | 563 |
|
|
2023
Q4 | $99 | Hold |
8
| – | – | ﹤0.01% | 544 |
|
|
2023
Q3 | $199 | Hold |
8
| – | – | ﹤0.01% | 531 |
|
|
2023
Q2 | $219 | Hold |
8
| – | – | ﹤0.01% | 471 |
|
|
2023
Q1 | $195 | Hold |
8
| – | – | ﹤0.01% | 483 |
|
|
2022
Q4 | $161 | Hold |
8
| – | – | ﹤0.01% | 461 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 510 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 523 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 502 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 523 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 507 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 497 |
|
|
2021
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 439 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 407 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 389 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 413 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 403 |
|
|
2019
Q4 | $1K | Buy |
+8
| New | +$432 | ﹤0.01% | 358 |
|
Other funds holding SER
Pacifica Partners's SER Position: Q3 2026 in Review
Pacifica Partners held its Serina Therapeutics (SER) position steady in Q3 2026 at 8 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #402.
Pacifica Partners first reported a position in SER in Q4 2019 and has held it in 27 quarters since. The position peaked at $1K in Q4 2019. 3 funds tracked by Wall St. Rank hold SER as of Q3 2026.
- Pacifica Partners held 8 shares of Serina Therapeutics worth $16 as of Q3 2026.
- Pacifica Partners left its Serina Therapeutics share count unchanged in Q3 2026.
- Serina Therapeutics made up ﹤0.01% of Pacifica Partners's portfolio in Q3 2026, its #402 holding.
- Pacifica Partners first reported a position in Serina Therapeutics in Q4 2019 and has held it in 27 quarters since.
- Pacifica Partners's Serina Therapeutics position peaked at $1K in Q4 2019.
- 3 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.